AI Article Synopsis
- There is an increasing amount of grey literature accessible to nurses, which includes various non-traditional sources such as oral presentations and personal communications.
- This type of literature encompasses items like leaflets, newspapers, magazines, unpublished research, and internal reports, making it diverse.
- Grey literature can serve as a valuable resource for research, providing insights and information that may not be found in formal publications.
Article Abstract
An ever-growing amount of grey literature is available to nurses, including oral presentations, personal communication, leaflets, newspapers and magazines, unpublished research, internal reports and minutes of meetings. It can be an invaluable research resource.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Early events in G-quadruplex folding captured by time-resolved small-angle X-ray scattering.
Nucleic Acids Res
January 2025
Department of Medicine, UofL Health Brown Cancer Center, University of Louisville, Louisville KY, 505 S Hancock St, Louisville, KY 40202, United States.
Time-resolved small-angle X-ray experiments are reported here that capture and quantify a previously unknown rapid collapse of the unfolded oligonucleotide as an early step in the folding of hybrid 1 and hybrid 2 telomeric G-quadruplex structures. The rapid collapse, initiated by a pH jump, is characterized by an exponential decrease in the radius of gyration from 24.3 to 12.
View Article and Find Full Text PDFScoping Review: A Hybrid Delivery Model of Pain Management.
Pain Manag Nurs
January 2025
School of Nursing, Excelsior University, Albany, NY. Electronic address:
Objectives: This scoping review explores hybrid healthcare models combining telehealth and in-person visits for pain management. It examines their components, effectiveness compared to traditional care, advantages, and disadvantages of telehealth, and the influence of future technologies.
Design: The review followed the JBI scoping review methodology and used the PRISMA-ScR checklist.
Social inclusion programming for older adults living in age-friendly cities: a scoping review.
BMJ Open
January 2025
Wilfrid Laurier University, Waterloo, Ontario, Canada.
Objectives: Creating age-friendly cities (AFCs) is essential for supporting older adults' well-being. The WHO's 2007 guide outlines key features of AFCs, including social inclusion. Despite increasing numbers of AFC programmes, diverse experiences of ageing are often overlooked.
View Article and Find Full Text PDFSuccessful open defecation-free intervention in low- and middle-income countries: a qualitative synthesis systematic review protocol.
BMJ Open
January 2025
Department of Health Behavior, Environment and Social Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Daerah Istimewa Yogyakarta, Indonesia
Introduction: The results of open defecation-free (ODF) programmes vary greatly, especially in low- and middle-income countries (LMICs). This study will systematically investigate available qualitative research to identify the elements contributing to open defecation programmes' effectiveness in various situations across LMICs. Furthermore, this review seeks to identify gaps in the available literature and areas that require additional investigation and action.
View Article and Find Full Text PDFClinical effectiveness and implementation outcomes of pMDI-to-DPI switch in children between 5 and 12 years of age: a scoping review protocol.
BMJ Open
January 2025
Centre for Behavioural and Implementation Science Interventions, National University of Singapore Yong Loo Lin School of Medicine, Singapore.
Introduction: Inhalers are critical in asthma treatment, and inappropriate inhaler use leads to poor asthma outcomes. In adults and adolescents, dry powder inhalers (DPIs) are safe and effective alternatives to mainstay pressurised metered dose inhalers and could bridge the asthma care gap while also reducing the environmental burden of asthma care. Despite being licensed for use in ages 5 years old and older, the evidence for clinical effectiveness is less clear for patients between ages 5 and 12 years.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!